Elizabeth Williams

About Elizabeth Williams

Elizabeth Williams, With an exceptional h-index of 50 and a recent h-index of 33 (since 2020), a distinguished researcher at Queensland University of Technology, specializes in the field of prostate cancer, bladder cancer, EMT, epithelial mesenchymal plasticity.

His recent articles reflect a diverse array of research interests and contributions to the field:

Defining the challenges and opportunities for using patient‐derived models in prostate cancer research

Introduction of Androgen Receptor Targeting shRNA Inhibits Tumor Growth in Patient-Derived Prostate Cancer Xenografts

Performance of tumour microenvironment deconvolution methods in breast cancer using single-cell simulated bulk mixtures

Characterisation of cell lines derived from prostate cancer patients with localised disease

Dissecting the Molecular Profiles of Circulating Tumor Cells in Models of Breast and Prostate Cancers

hSSB1 (NABP2/OBFC2B) modulates the DNA damage and androgen‐induced transcriptional response in prostate cancer

Computationally efficient framework for diagnosing, understanding and predicting biphasic population growth

Spatial expression of the FGFR2b splice isoform and its prognostic significance in endometrioid endometrial carcinoma

Elizabeth Williams Information

University

Position

___

Citations(all)

10782

Citations(since 2020)

5201

Cited By

7101

hIndex(all)

50

hIndex(since 2020)

33

i10Index(all)

99

i10Index(since 2020)

80

Email

University Profile Page

Google Scholar

Elizabeth Williams Skills & Research Interests

prostate cancer

bladder cancer

EMT

epithelial mesenchymal plasticity

Top articles of Elizabeth Williams

Defining the challenges and opportunities for using patient‐derived models in prostate cancer research

2024/5

Introduction of Androgen Receptor Targeting shRNA Inhibits Tumor Growth in Patient-Derived Prostate Cancer Xenografts

Current Oncology

2023/10/24

Performance of tumour microenvironment deconvolution methods in breast cancer using single-cell simulated bulk mixtures

Nature Communications

2023/9/16

Characterisation of cell lines derived from prostate cancer patients with localised disease

Prostate Cancer and Prostatic Diseases

2023/9

Dissecting the Molecular Profiles of Circulating Tumor Cells in Models of Breast and Prostate Cancers

2023/8/2

hSSB1 (NABP2/OBFC2B) modulates the DNA damage and androgen‐induced transcriptional response in prostate cancer

The Prostate

2023/5

Computationally efficient framework for diagnosing, understanding and predicting biphasic population growth

Journal of the Royal Society Interface

2022/12/7

Spatial expression of the FGFR2b splice isoform and its prognostic significance in endometrioid endometrial carcinoma

The Journal of Pathology: Clinical Research

2022/11

Urothelial carcinoma and prostate-specific membrane antigen: cellular, imaging, and prognostic implications

2022/9/1

Direct bone marrow injection of human bone marrow-derived stromal cells into mouse femurs results in greater prostate cancer PC-3 cell proliferation, but not specifically …

BMC cancer

2022/5/17

Circulating tumour cells indicate the presence of residual disease post-castration in prostate cancer patient-derived xenograft models

Frontiers in Cell and Developmental Biology

2022/4/13

Chimeric antigen receptor T-cell therapy in metastatic castrate-resistant prostate cancer

2022/1/20

Modelling the tumor immune microenvironment for precision immunotherapy

2022

A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells

Communications Biology

2021/8/30

Isomer-resolved imaging of prostate cancer tissues reveals specific lipid unsaturation profiles associated with lymphocytes and abnormal prostate epithelia

Frontiers in endocrinology

2021/8/5

Epithelial-to-mesenchymal transition enhances cancer cell sensitivity to cytotoxic effects of cold atmospheric plasmas in breast and bladder cancer systems

Cancers

2021/6/9

A suite of activity-based probes to dissect the KLK activome in drug-resistant prostate cancer

Journal of the American Chemical Society

2021/6/4

Diversity of epithelial-mesenchymal phenotypes in circulating tumour cells from prostate cancer patient-derived xenograft models

Cancers

2021/6/1

Fibroblast growth factor receptor 2 isoforms detected via novel RNA ISH as predictive biomarkers for progestin therapy in atypical hyperplasia and low-grade endometrial cancer

Cancers

2021/4/3

ELOVL5 is a critical and targetable fatty acid elongase in prostate cancer

Cancer research

2021/4/1

See List of Professors in Elizabeth Williams University(Queensland University of Technology)